CLINICAL AND LABORATORY CHARACTERISTICS OF PRIMARY MYELODYSPLASTIC SYNDROMES

Nguyễn Quang Hưng1,, Vũ Đức Bình1, Lê Quang Tường1, Nguyễn Bá Cương1, Nguyễn Thị Thuỳ Linh1, Nguyễn Hà Thanh1,2
1 National Institute of Hematology and Blood Transfusion
2 Hanoi Medical University

Main Article Content

Abstract

A cross-sectional descriptive study was carried out to investigate some clinical and laboratory features of primary myelodysplastic syndromes according to WHO-2008 classification. The study was conducted on 104 patients diagnosed with primary myelodysplastic syndrome who were admitted to the hospital for the first time at the National Institute of Hematology and Blood Transfusion. The study results showed that the most common types of diseases in primary myelodysplastic syndrome according to WHO-2008 classification was RCMD (53.8%); followed by RAEB-1 form (23.1%); RAEB-2 (14.4%); rare forms of RA, RN, RT, MDS-U and Del-5q. Anemia symptoms were found in most of the patients (95.2%) of which 16.3% were severe anemia. 26.9% of patients had bleeding, mainly subcutaneous bleeding. 13.5% of patients presented with fever/infection. Peripheral blood decreased one, two, or all three cell lines. Peripheral blood morphological disorders were expressed in all three cell lines: erythrocyte polymorphism, irregular size, specific decrease or loss of protoplasmic neutrophils, macrocytic or stunted platelets.

Article Details

References

1. Nösslinger, T., et al., Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution. Blood, 2001. 98(10): p. 2935-41.
2. Vardiman, J.W., N.L. Harris, and R.D. Brunning, The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 2002. 100(7): p. 2292-302.
3. Trí, N.A., Hội chứng rối loạn sinh tủy. Tiền Lơ xê mi và Lơ xê mi cấp. 2010: p. 59-140.
4. Della Porta, M.G., et al., Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome. Haematologica, 2011. 96(3): p. 441-9.
5. Nga, N.T.Q., Đặc điểm lâm sàng huyết học của hội chứng rối loạn sinh tủy nguyên phát tại Viện Huyết học – Truyền máu. 2003. p. 8-12.
6. Claire Pomeroyace, e.a., Infection in the myelodysplastic syndromes. The American Journal of Cardiology, 1990. 1.
7. Pomeroy, C., et al., Infection in the myelodysplastic syndromes. Am J Med, 1991. 90(3): p. 338-44.
8. Chessells, J.M., 7 Myelodysplasia. Baillière's Clinical Haematology, 1991. 4(2): p. 459-482.